Concord Biotech Ltd. · CONCORDBIO
Every Concord Biotech Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY HEALTHCARE INDEX. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
13results judged
1read right
2read wrong
2flat / no call
8unread
46%beat the market
+2.9%avg vs market, 10d
4.9%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| neutral | 2 | 0 | 0 | 2 | — | +3.8% | |
| unfavourable | 2 | 0 | 2 | 0 | 0% | +18.5% | |
| weak | 1 | 1 | 0 | 0 | 100% | -4.1% | |
| unread | 8 | 0 | 0 | 0 | — | -0.4% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
13 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 31 Jul Q1FY27 | unfavourable | wrong | -0.1% | +6.6% | +7.0% | +8% | no figures |
|
› |
| 29 May Q4FY26 | unfavourable | wrong | +10.9% | +31.3% | +30.0% | +1% | no figures |
|
› |
| 11 Feb Q3FY26 | neutral | neutral | -4.9% | +0.5% | +2.3% | -7% | no figures |
|
› |
| 13 Nov Q2FY26 | weak | right | +3.0% | -2.8% | -4.1% | -8% | no figures |
|
› |
| 8 Aug Q1FY26 | neutral | neutral | +3.1% | +6.8% | +5.3% | -12% | no figures |
|
› |
| 29 May Q4FY25 | — | unread | +9.1% | +26.6% | +27.0% | -4% | no figures |
|
› |
| 14 Feb Q3FY25 | — | unread | -20.3% | -28.0% | -24.0% | -0% | no figures |
|
› |
| 12 Nov Q2FY25 | — | unread | -1.6% | +9.8% | +9.3% | -8% | no figures |
|
› |
| 9 Aug Q1FY25 | — | unread | -4.7% | +1.7% | -2.0% | +6% | no figures |
|
› |
| 24 May Q4FY24 | — | unread | -1.3% | -0.4% | -1.8% | -5% | no figures |
|
› |
| 9 Feb Q3FY24 | — | unread | -2.7% | -0.0% | -2.3% | -1% | no figures |
|
› |
| 9 Nov Q2FY24 | — | unread | -1.7% | -5.0% | -6.8% | +32% | no figures |
|
› |
| 6 Sep Q1FY24 | — | unread | +0.8% | -2.3% | -2.6% | — | no figures |
|
› |